Biohacking News Podcast Por Inception Point Ai arte de portada

Biohacking News

Biohacking News

De: Inception Point Ai
Escúchala gratis

Biohacking News Tracker: Stay Ahead in the World of Biohacking

Welcome to "Biohacking News Tracker," your go-to podcast for the latest updates and breakthroughs in the world of biohacking. From cutting-edge technologies and genetic engineering to personalized health and wellness strategies, we cover it all. Each episode features expert interviews, in-depth analysis, and the most current news in biohacking and human optimization.

Join us as we explore the intersection of biology and technology, uncovering innovative ways to enhance human potential. Whether you're a biohacking enthusiast, a tech aficionado, or simply curious about the future of health, "Biohacking News Tracker" offers insightful and actionable information. Subscribe now and stay ahead in the rapidly evolving world of biohacking.

For more info https://www.quietperiodplease.com/Copyright 2025 Inception Point Ai Política y Gobierno
Episodios
  • Biohacking Market Boom: 18.75% Growth Through 2032, But Skepticism Rises

    Biohacking Market Boom: 18.75% Growth Through 2032, But Skepticism Rises
    Mar 20 2026
    The biohacking industry shows steady growth momentum over the past 48 hours, with no major disruptions but continued hype around cognitive and energy supplements. The global biohacking market was valued at USD 29,526.01 million in 2025 and is projected to reach USD 98,319.59 million by 2032, expanding at a compound annual growth rate of 18.75 percent.[1] This forecast, updated March 16, underscores robust long-term demand, though no fresh statistics from the last week alter this trajectory.

    Recent buzz centers on emerging products like a supplement formulation promoted by Ghassan Salame, marketed as a 2026 breakthrough for cognitive support and energy in biohacker circles.[2] No verified deals, partnerships, or new launches were confirmed in the past 48 hours, and regulatory changes remain absent from reports.

    Criticism highlights risks, with Salt Lake City exemplifying issues in the space: charismatic founders pushing compelling but unproven narratives.[3] This reflects ongoing consumer behavior shifts toward skepticism amid hype, contrasting quieter periods without such spotlight.

    No price changes, supply chain issues, or emerging competitors surfaced recently. Leaders like those behind these supplements respond by doubling down on marketing claims, prioritizing narrative over rigorous validation. Compared to prior reporting, current conditions mirror stable 2025 estimates without acceleration or downturns, signaling a maturing yet controversy-prone sector focused on wearables and nootropics. (248 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Más Menos
    2 m
  • Peptide Boom: FDA Loosening Rules, Market Hits $52.6B, What You Need to Know

    Peptide Boom: FDA Loosening Rules, Market Hits $52.6B, What You Need to Know
    Mar 19 2026
    In the past 48 hours, the biohacking industry shows momentum from regulatory shifts and product innovations, with RFK Jr. pushing to loosen FDA restrictions on nearly 20 peptides like ipamorelin, CJC-1295, BPC-157, and TB-500, potentially enabling U.S. compounding pharmacies to supply higher-quality versions and curb risky online imports.[1] This follows his recent Joe Rogan podcast comments, drawing support from physicians like Dr. Sue Decotiis for safer access under medical guidance, though experts caution on unproven safety and lack of human trials for many compounds.[1]

    Market data highlights growth: the global longevity ingredients sector, overlapping biohacking, hit $984.27 million in 2025 and projects $1,706.40 million by 2033 at 7.12% CAGR, with peptides and amino acids claiming 15% share; North America leads at 35%.[2] March 2026 saw spermidine supplements named U.S. award finalists for autophagy support and NAD+ injectable pens launch at wellness centers, signaling consumer shifts toward cellular repair tools.[2] Peptides overall reached a $52.6 billion market, with GLP-1 adoption at 1 in 8 U.S. adults.[8]

    New launches include U: The Mind Company's non-invasive brain device, an amplitude-modulated alternative to Neuralink, targeting focus and memory for biohackers; its Parkinson's trial is underway.[5] Weight-loss patches mimicking GLP-1 effects like Ozempic emerged as a 2026 trend, avoiding injections.[6]

    No major deals, disruptions, or price shifts reported in the last week, but leaders like Finnrick Analytics address supply impurities via testing.[1] Compared to early 2026's NAD+ gut health studies, current buzz amplifies peptides amid policy thaw, boosting influencer-driven demand without evident consumer pullback. Industry responds by prioritizing ethical sourcing and trials for credibility.[1][2] (298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Más Menos
    2 m
  • Biohacking Conferences 2026: From Optimization Fatigue to Invisible Health Tech

    Biohacking Conferences 2026: From Optimization Fatigue to Invisible Health Tech
    Mar 18 2026
    The biohacking industry shows steady momentum in the past 48 hours, driven by major conference announcements rather than market disruptions or new deals. On March 17, 2026, Biohackers World revealed plans for its March 28-29 Los Angeles event, expecting over 1,500 attendees, 35 speakers, and 75 exhibitors focused on longevity science, AI health data, microbiome research, and testable wellness tech like light therapies.[1] Similarly, Dave Asprey announced the speaker lineup for his 14th annual BEYOND Biohacking Conference on May 27-29 in Austin, featuring experts like Jay Shetty, Dr. Gabrielle Lyon, and Patrick Kennedy, with 150 exhibitors offering PEMF therapy, stem cells, and hyperbaric oxygen.[2][3]

    No verified market movements, price changes, partnerships, regulatory shifts, or supply chain issues emerged in the last week; data remains sparse. The global wellness economy, tied to biohacking, hit 5.6 trillion dollars in 2023 and is projected to reach 8.5 trillion by 2027, reflecting sustained growth in wearables and metabolic tracking.[1]

    Consumer behavior hints at a backlash against over-optimization, with fatigue from constant self-surveillance pushing toward "invisible care" tech that embeds health monitoring without screens, per 2026 wellness trends.[5] New product launches include Reaper's Remedies "Die Slower" vitamins on March 17, satirizing longevity hype in a crowded field.[7]

    Leaders like Asprey respond by expanding beyond protocols to consciousness and nervous system regulation, emphasizing meaningful life over mere lifespan extension.[2][3] Mick Safron of Biohackers World highlights a shift from quick fixes to structured, data-driven everyday health.[1] Compared to prior reporting, this builds on rising preventive health interest without major pivots, positioning Austin and LA as hubs amid no evident disruptions. Overall, the sector buzzes with events amid subtle consumer pushback on hyper-tracking.(298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI
    Más Menos
    2 m
Todavía no hay opiniones